CompletedNot Applicable

Optimal Treatment of Miscarriage

Sweden190 participantsStarted 2008-10-01

Plain-language summary

The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * nonviable intrauterine pregnancy with retained gestational sac in the uterus * the embryo if visible 5 to 35 mm without a heart beat * vaginal bleeding * circulatory stable * hemoglobin at least 80 g/L Exclusion Criteria: * contraindications against misoprostol

What they're measuring

complete miscarriage

Timeframe: 10 days

Trial details

NCT IDNCT01033903

SponsorRegion Skane

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Abortion, Spontaneous trials